Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial

Judith C. Marsh, Simon J. Stanworth, Laura A. Pankhurst, Delordson Kallon, Adeline Z. Gilbertson, Collette Pigden, Alison J. Deary, Ana S. Mora, Joanne Brown, Emma S. Laing, Louise L. Choo, Renate Hodge, Charlotte A. Llewelyn, Kay Harding, Deborah Sage, Aleksandar Mijovic, Ghulam J. Mufti, Cristina V. Navarrete, Colin J. Brown

Blood (2021) 137 (3): 310–322.

https://doi.org/10.1182/blood.2020007199

Published: 2021

Includes: Supplemental data

Journal Articles

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Meng Wang, MD PhD, Wenjia Wang, PhD, Ayesha Abeywardane, MD, Malinthi Adikarama, MD, Donal McLornan, MD PhD FRCPath, Kavita Raj, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Stephen Devereux, MD PhD FRCPath, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MD FRCP, FRCPath, Victoria T Potter, MD FRCPA, FRACP, Aleksandar Mijovic

Blood (2014) 124 (21): 2512.

https://doi.org/10.1182/blood.V124.21.2512.2512

Published: 2014

Journal Articles

Delayed Hemolytic Transfusion Reactions in Adults with Sickle Cell Disease: Experience of a Single Institution in the UK

Jennifer Vidler, Kate Gardner, Aleksandar Mijovic, Swee Lay Thein

Blood (2014) 124 (21): 4079.

https://doi.org/10.1182/blood.V124.21.4079.4079

Published: 2014

Journal Articles

Long Term Outcomes of Adults Undergoing Alemtuzumab-Based Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation.

M. Mansour Ceesay, MRCPath, ZiYi Lim, MRCPath, Michelle Kenyon, Aloysius Y.L. Ho, FRCPath, Stephen Devereux, FRCPath, Steve Schey, FRCPath, Aleksandar Mijovic, FRCPath, Antonio Pagliuca, FRCPath, Ghulam J. Mufti, FRCPath

Blood (2007) 110 (11): 1665.

https://doi.org/10.1182/blood.V110.11.1665.1665

Published: 2007

Journal Articles

Reduced-Intensity Transplants - Red Cell Antigens, Antibodies, and Blood Product Usage.

Aleksandar Mijovic, MBBS, PhD, FRCPath, Atiyeh M. Abdallah, MSc, PhD, Ghulam J. Mufti, MBBS,MD,FRCPath

Blood (2006) 108 (11): 2986.

https://doi.org/10.1182/blood.V108.11.2986.2986

Published: 2006

Journal Articles

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

Aloysius Y. L. Ho, Antonio Pagliuca, Michelle Kenyon, Jane E. Parker, Aleksandar Mijovic, Stephen Devereux, Ghulam J. Mufti

Blood (2004) 104 (6): 1616–1623.

https://doi.org/10.1182/blood-2003-12-4207

Published: 2004

Journal Articles

The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS

Jane E. Parker, Ghulam J. Mufti, Feyrooz Rasool, Aleksandar Mijovic, Stephen Devereux, Antonio Pagliuca

Blood (2000) 96 (12): 3932–3938.

https://doi.org/10.1182/blood.V96.12.3932

Published: 2000

NARROW

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Delayed Hemolytic Transfusion Reactions in Adults with Sickle Cell Disease: Experience of a Single Institution in the UK

Long Term Outcomes of Adults Undergoing Alemtuzumab-Based Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation.

Reduced-Intensity Transplants - Red Cell Antigens, Antibodies, and Blood Product Usage.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS

Email alerts

ASH Publications

American Society of Hematology

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Delayed Hemolytic Transfusion Reactions in Adults with Sickle Cell Disease: Experience of a Single Institution in the UK

Long Term Outcomes of Adults Undergoing Alemtuzumab-Based Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation.

Reduced-Intensity Transplants - Red Cell Antigens, Antibodies, and Blood Product Usage.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only